For people struggling with both diabetes and a common type of heart failure, the weight-loss drug Wegovy may do more for their health than help them shed pounds, new research suggests. In the study, published Saturday in the New England Journal of Medicine, researchers...
For people struggling with both diabetes and a common type of heart failure , the weight-loss drug Wegovy may do more for their health than help them shed pounds, new research suggests.
“I think that’s incredibly exciting because first of all, these patients are really difficult to treat and there are a lot more of them every day,” Kosiborod said. “And until recently, we had very little to offer them, so if we know it actually modifies the disease process, we have something really effective — and by the way, really well-tolerated as well — and that’s, of course, great news for patients and great news for doctors taking care of patients.
Wegovy was first approved in 2021 to treat obesity. Just last month, the U.S. Food and Drug Administration also approved Wegovy to reduce the risk of cardiovascular death, heart attack and stroke in obese/overweight adults with heart disease. This latest study offers up fresh evidence that Wegovy’s benefits extend to people with diabetes.
Patients who got Wegovy had much better outcomes, with more weight loss and a bigger reduction in heart failure-related symptoms and physical limitations. They also could walk farther over the course of six minutes and showed improvements in biomarkers for inflammation.
Diabetes Type 2 Heart Failure Weight Loss
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA Approves Wegovy For Heart Conditions in Game-Changing MoveThe Best in Science News and Amazing Breakthroughs
Read more »
FDA approves Novo Nordisk's Wegovy for lowering heart risksThe Food and Drug Administration approved Novo Nordisk's weight-loss drug Wegovy on Friday for lowering the risk of stroke and heart attack in overweight or obese adults who do not have diabetes.
Read more »
Ozempic And Wegovy Rivals: Here Are The Companies Working On Competitor Weight Loss DrugsI am a senior reporter for the Forbes breaking news team, covering health and science from the London office. Previously I worked as a reporter for a trade publication covering big data and law and as a freelance journalist and policy analyst covering science, tech and health.
Read more »
Weight loss drugs Wegovy and Zepbound remain out of reach for many who need themBerkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He previously covered the biotech and pharmaceutical industry with CNBC.
Read more »
Medicare will cover Wegovy to reduce heart disease riskBerkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He previously covered the biotech and pharmaceutical industry with CNBC.
Read more »
Medicare can pay for obesity drugs like Wegovy in certain heart patientsCertain Medicare patients may get help paying for the popular weight-loss drug Wegovy, as long as they also have heart disease.
Read more »